A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/24/2004	CN1549823A Production of high molecular mass lectins
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/24/2004	CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549729A 化合物 Compound
11/24/2004	CN1549728A Immune composition containing antigen, gene vector and adjuvant
11/24/2004	CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549712A Antitumor agents and process for producing the same
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1548542A Recombinant DNA plasmid, its construction process, mutivalent vaccine containing the plasmid and its application
11/24/2004	CN1548530A Interaction and influence on proliferation of neure cell of BEX1, LMO2 and SNF5
11/24/2004	CN1548457A Tumor antigen protein and tumor antigen peptide
11/24/2004	CN1548455A Tumor antigen protein and tumor antigen peptide
11/24/2004	CN1548445A N-crotonoyl hydroxy protected glucosamine and its prepn and application
11/24/2004	CN1548434A Benzothiophene compounds and their prepn and medicine use
11/24/2004	CN1548367A Nano level active carbon and its prepn and use
11/24/2004	CN1548159A Composite magnetic material and its use in treating cancer
11/24/2004	CN1548151A Combined biological medicine with active enzyme
11/24/2004	CN1548132A Common jujube seed extract and its use
11/24/2004	CN1548085A Compound cantharides bolus and its prepn
11/24/2004	CN1548057A Transfusing agent of active carbon and its prepn and application in preparing cancer-treating medicine
11/24/2004	CN1548040A Application of skullcap root extract in preparing medicine for nasopharyngeal carcinoma
11/24/2004	CN1548036A Medicine containing acarnine compound as active component
11/24/2004	CN1177057C Recombinant of viral vector and human tumor suppressor gene, and use thereof
11/24/2004	CN1177053C Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1177042C Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application
11/24/2004	CN1176946C New-type alpha-interferon
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176937C Double-stranded RNA and use thereof
11/24/2004	CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/24/2004	CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities
11/24/2004	CN1176914C Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives
11/24/2004	CN1176720C Hyacinth bletilla micro-balls for liver and kidney arterial embolism
11/24/2004	CN1176718C Thymosin alpha-1 microball prepn and its prepn process
11/24/2004	CN1176714C Method and composition for treating prostate cancer
11/24/2004	CN1176712C Glossy ganoderma and selenium composite medicine material crude slices
11/24/2004	CN1176706C Medicine for treating leukemia preparing method thereof
11/24/2004	CN1176695C Chinese herb medicine for treating liver diseases
11/24/2004	CN1176665C Medicine for treating maligant leucoma and its compounding process
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/23/2004	US6822141 Diacylglycerol acyl transferase proteins
11/23/2004	US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition
11/23/2004	US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004	US6822074 Comprises cyclization of precursor; for improved yield
11/23/2004	US6822001 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
11/23/2004	US6821989 Using a tamoxifen type compound
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821973 Compounds
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004	US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004	US6821549 Contacting stent with a coating solution containing a coating material to be deposited on surface of stent; inserting thread through the lumen of the stent; producing relative motion between stent and thread to remove coating material
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2294158C Natural antitumor or antiviral substances and use of the same
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/23/2004	CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts
11/23/2004	CA2059052C Phenylimidazolidines, process for their preparation, their application as medicaments and pharmaceutical compositions containing them
11/18/2004	WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
11/18/2004	WO2004099254A2 Activation of recombinant diphtheria toxin fusion proteins by specific proteases highly expressed on the surface of tumor cells
11/18/2004	WO2004099247A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	WO2004099193A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof
11/18/2004	WO2004099190A1 Novel substituted benzimidazole derivatives
11/18/2004	WO2004099188A1 Antitumoral antiadrogenic pyrrolidines
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099162A1 Polycyclic diazodioxide-based bcl-2 protein antagonist
11/18/2004	WO2004099158A1 Monocyclic diazodioxide based bcl-2 protein antagonists
11/18/2004	WO2004098652A1 Radiolabelled thyroid stimulating hormone (tsh) and use thereof for the diagnosis and therapy of the differentiated thyroid tumors
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098638A1 Effector cell function inhibitor
11/18/2004	WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004	WO2004098626A2 The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
11/18/2004	WO2004098620A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer
11/18/2004	WO2004098613A1 Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
11/18/2004	WO2004098604A1 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use
11/18/2004	WO2004098501A2 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
11/18/2004	WO2004078205A8 Targeting a protein prc1 for the treatment of pancreatic cancer
11/18/2004	WO2004078097A8 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
11/18/2004	WO2004073613A3 A medicine and food
11/18/2004	WO2004073593A3 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2004034970A3 Macrocyclic lactams
11/18/2004	WO2004024755A3 Sarcolysyl derivatives and method for the production thereof
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment

1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 2211